These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31899478)

  • 1. Baseline 10-Year Cardiovascular Risk Scores Predict Cognitive Function in Older Persons, and Particularly Women, Living With Human Immunodeficiency Virus Infection.
    Chow FC; Lyass A; Mahoney TF; Massaro JM; Triant VA; Wu K; Berzins B; Robertson K; Ellis RJ; Tassiopoulos K; Taiwo B; D'Agostino RB
    Clin Infect Dis; 2020 Dec; 71(12):3079-3085. PubMed ID: 31899478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population.
    Schulz CA; Mavarani L; Reinsch N; Albayrak-Rena S; Potthoff A; Brockmeyer N; Hower M; Erbel R; Jöckel KH; Schmidt B; Esser S;
    HIV Med; 2021 Sep; 22(8):732-741. PubMed ID: 34028959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between change in cardiovascular risk scores and future cardiovascular disease: analyses of data from the Whitehall II longitudinal, prospective cohort study.
    Lindbohm JV; Sipilä PN; Mars N; Knüppel A; Pentti J; Nyberg ST; Frank P; Ahmadi-Abhari S; Brunner EJ; Shipley MJ; Singh-Manoux A; Tabak AG; Batty GD; Kivimäki M
    Lancet Digit Health; 2021 Jul; 3(7):e434-e444. PubMed ID: 34167764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
    Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
    HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid magnetic resonance imaging in persons living with HIV and 10-year atherosclerotic cardiovascular disease risk score.
    Mee TC; Aepfelbacher J; Krakora R; Chairez C; Kvaratskhelia N; Smith B; Sandfort V; Hadigan C; Morse C; Hammoud DA
    Antivir Ther; 2018; 23(8):695-698. PubMed ID: 30088806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
    Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China.
    Jiang Y; Ma R; Guo H; Zhang X; Wang X; Wang K; Hu Y; Keerman M; Yan Y; Ma J; Song Y; Zhang J; He J; Guo S
    BMC Public Health; 2020 Sep; 20(1):1471. PubMed ID: 32993590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Subclinical Vascular Damage in People Living With HIV Is Not Predicted by Current Cardiovascular Risk Scores: A Prospective 3-Year Study.
    Kapelios CJ; Argyris AA; Protogerou AD; Katsarolis I; Arida A; Papadopoulou M; Ntaroutsou E; Kitas G; Sfikakis PP; Psichogiou M
    J Acquir Immune Defic Syndr; 2020 Apr; 83(5):504-512. PubMed ID: 31923089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan.
    Wu PY; Chen MY; Sheng WH; Hsieh SM; Chuang YC; Cheng A; Pan SC; Wu UI; Chang HY; Luo YZ; Yang SP; Zhang JY; Sun HY; Hung CC
    J Microbiol Immunol Infect; 2019 Aug; 52(4):549-555. PubMed ID: 31036484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations.
    Achhra AC; Lyass A; Borowsky L; Bogorodskaya M; Plutzky J; Massaro JM; D'Agostino RB; Triant VA
    Curr HIV/AIDS Rep; 2021 Aug; 18(4):271-279. PubMed ID: 34247329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of 2 risk prediction models in predicting the risk of atherosclerosis in patients with chronic kidney disease.
    Chen S; Li N; Shen Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):966-973. PubMed ID: 34707006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cardiovascular risk patients benefit more from bariatric surgery than low cardiovascular risk patients.
    Blanco DG; Funes DR; Giambartolomei G; Lo Menzo E; Szomstein S; Rosenthal RJ
    Surg Endosc; 2019 May; 33(5):1626-1631. PubMed ID: 30225605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study.
    Woldu M; Minzi O; Shibeshi W; Shewaamare A; Engidawork E
    PLoS One; 2021; 16(11):e0260109. PubMed ID: 34843544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Asgari S; Moosaie F; Orangi M; Sarvghadi F; Khalili D; Azizi F
    J Transl Med; 2021 Jan; 19(1):25. PubMed ID: 33407576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related Factors.
    Judd A; Le Prevost M; Melvin D; Arenas-Pinto A; Parrott F; Winston A; Foster C; Sturgeon K; Rowson K; Gibb DM;
    Clin Infect Dis; 2016 Nov; 63(10):1380-1387. PubMed ID: 27581764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk assessment in people living with HIV compared to the general population.
    Delabays B; Cavassini M; Damas J; Beuret H; Calmy A; Hasse B; Bucher HC; Frischknecht M; Müller O; Méan M; Vollenweider P; Marques-Vidal P; Vaucher J
    Eur J Prev Cardiol; 2022 Mar; 29(4):689-699. PubMed ID: 34893801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.